We are live on ! Find out more
PCM

Polaris Capital Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 40.82%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+40.82%
3 Year Est. Return
+94.3%
5 Year Est. Return
+113.49%
10 Year Est. Return
+358.47%
AUM
$3.1B
AUM Growth
+$51.4M
Cap. Flow
+$102M
Cap. Flow %
3.28%
Top 10 Hldgs %
48.78%
Holding
106
New
4
Increased
29
Reduced
19
Closed
3

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$224M
2
NEE icon
NextEra Energy
NEE
+$1.22M
3
MTB icon
M&T Bank
MTB
+$1.11M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.01M
5
ALE
Allete
ALE
+$989K

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$52.7M
2
DGX icon
Quest Diagnostics
DGX
+$44.3M
3
BPOP icon
Popular Inc
BPOP
+$18.6M
4
INFY icon
Infosys
INFY
+$13.8M
5
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$1.93M

Sector Composition

Rank Sector Weight
1 Financials 27.15%
2 Healthcare 18.38%
3 Technology 13.56%
4 Consumer Staples 10.23%
5 Consumer Discretionary 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CB icon
26
Chubb
CB
$135B
$49.3M 1.59%
310,049
+4,300
+1% +$713K
UNH icon
27
UnitedHealth
UNH
$370B
$49M 1.58%
122,256
+2,400
+2% +$957K
INGR icon
28
Ingredion
INGR
$6.58B
$48.4M 1.56%
534,700
+5,000
+0.9% +$467K
CRI icon
29
Carter's
CRI
$1.47B
$48.1M 1.55%
466,213
-200
-0% -$20.4K
ABBV icon
30
AbbVie
ABBV
$435B
$47.9M 1.54%
424,815
+5,100
+1% +$574K
GD icon
31
General Dynamics
GD
$106B
$47.3M 1.52%
250,993
+1,700
+0.7% +$321K
INTC icon
32
Intel
INTC
$513B
$46.4M 1.5%
825,819
+14,800
+2% +$869K
SAIC icon
33
Saic
SAIC
$5.35B
$42M 1.35%
478,300
-2,000
-0.4% -$179K
MTB icon
34
M&T Bank
MTB
$36.2B
$39.2M 1.26%
269,794
+7,100
+3% +$1.11M
NEE icon
35
NextEra Energy
NEE
$177B
$39.2M 1.26%
534,664
+16,200
+3% +$1.22M
VZ icon
36
Verizon
VZ
$196B
$33.1M 1.07%
591,434
+1,200
+0.2% +$68.9K
AVT icon
37
Avnet
AVT
$7.92B
$32.5M 1.05%
811,418
+20,100
+3% +$865K
DCOM icon
38
Dime Commercial Bancshares
DCOM
$1.78B
$20.7M 0.67%
614,780
+3,000
+0.5% +$101K
BRKL
39
DELISTED
Brookline Bancorp
BRKL
$18.5M 0.6%
1,235,586
– –
CATC
40
DELISTED
CAMBRIDGE BANCORP
CATC
$15.4M 0.5%
185,257
– –
PFC
41
DELISTED
Premier Financial Corp. Common Stock
PFC
$15.1M 0.49%
530,583
+13,100
+3% +$406K
TGLS icon
42
Tecnoglass Holdings Inc.
TGLS
$1.96B
$8.43M 0.27%
393,764
– –
CBAN icon
43
Colony Bankcorp
CBAN
$467M
$6.93M 0.22%
387,850
– –
SPFI icon
44
South Plains Financial
SPFI
$841M
$4.42M 0.14%
191,100
– –
OFG icon
45
OFG Bancorp
OFG
$2.21B
$4.32M 0.14%
195,300
– –
EBC icon
46
Eastern Bankshares
EBC
$5.23B
$4.11M 0.13%
200,000
– –
KFRC icon
47
Kforce
KFRC
$1.06B
$2.52M 0.08%
40,094
-3,900
-9% -$231K
FANG icon
48
Diamondback Energy
FANG
$52.7B
$2.5M 0.08%
26,570
– –
MEI icon
49
Methode Electronics
MEI
$592M
$2.29M 0.07%
46,600
– –
EVTC icon
50
Evertec
EVTC
$1.78B
$2.22M 0.07%
50,800
– –
1
2
3 4 5

Similar funds

BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
EC
E20 Capital Hong Kong $1.07B AUM
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
PP
Passaic Partners Newark, New Jersey $1.07B AUM 16.56% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Polaris Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Polaris Capital Management held 106 positions worth $3.1B, up 1.7% from $3.05B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Polaris Capital Management deployed $102M of net new capital in Q2 2021, opening 4 new positions and adding to 29 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 1,292,760 shares worth $230M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Quest Diagnostics, an estimated $44.3M trimmed.

  • Polaris Capital Management's largest Q2 2021 buy was Jazz Pharmaceuticals: 1,292,760 shares worth $230M.
  • Polaris Capital Management added most to NextEra Energy in Q2 2021, an estimated $1.22M increase.
  • Polaris Capital Management's biggest Q2 2021 reduction was Quest Diagnostics, cutting an estimated $44.3M.
  • Polaris Capital Management fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $52.7M.
  • Polaris Capital Management's ten largest holdings make up 49% of its $3.1B portfolio in Q2 2021.
  • Polaris Capital Management opened 4 new positions and closed 3 in Q2 2021.
  • Polaris Capital Management's portfolio value rose 1.7% quarter-over-quarter to $3.1B.

Based on Polaris Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.